Dane Andreeff - Nov 22, 2022 Form 4/A - Amendment Insider Report for HELIUS MEDICAL TECHNOLOGIES, INC. (HSDT)

Role: President and CEO, Director, 10%+ Owner
Signature: /s/ Dane Andreeff
Stock symbol: HSDT
Transactions as of: Nov 22, 2022
Transactions value $: $29,613
Form type: 4/A - Amendment
Date filed: 11/25/2022, 03:26 PM
Date Of Original Report: Nov 23, 2022
Previous filing: Nov 18, 2022
Next filing: Dec 19, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HSDT	Common Stock	Purchase	$2.92K	+10.3K	+4.94%	$0.28	219K	Nov 22, 2022	See footnote	F1, F2
transaction	HSDT	Common Stock	Purchase	$13.1K	+42.2K	+19.27%	$0.31	261K	Nov 23, 2022	See footnote	F1, F2
transaction	HSDT	Common Stock	Purchase	$3.15K	+10.1K	+23.01%	$0.31	54K	Nov 23, 2022	See footnote	F1, F3
transaction	HSDT	Common Stock	Purchase	$9.61K	+30.8K	+11.17%	$0.31	307K	Nov 23, 2022	See footnote	F1, F4
transaction	HSDT	Common Stock	Purchase	$782	+2.51K	+22.96%	$0.31	13.4K	Nov 23, 2022	See footnote	F1, F5
holding	HSDT	Common Stock						1.51K	Nov 22, 2022	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This Form 4/A is being filed to amend an inadvertent error in the number of shares purchased by the Reporting Person in the Form 4 previously filed on November 23, 2022.
F2	The shares are held by Maple Leaf Partners, L.P. ("MLP"). The reporting person is the managing member of Maple Leaf Capital I, LLC ("Maple Leaf Capital"), the general partner of MLP and as such may be deemed to beneficially own the securities owned by MLP. The reporting person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.
F3	The shares are held by Maple Leaf Partners I, L.P. ("MLP I"). The reporting person is the managing member of Maple Leaf Capital, the general partner of MLP I and as such may be deemed to beneficially own the securities owned by MLP I. The reporting person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.
F4	The shares are held by Maple Leaf Discovery I, L.P. ("MLD I"). The reporting person is the managing member of Maple Leaf Capital, the general partner of MLD I and as such may be deemed to beneficially own the securities owned by MLD I. The reporting person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.
F5	The shares are held by Maple Leaf Offshore Ltd. ("MLO"). The reporting person is the president of the managing member of Andreeff Equity Advisors, L.L.C., the investment manager of MLO and as such may be deemed to beneficially own the securities owned by MLO. The reporting person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.